📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sangart

1.1 - Company Overview

Sangart Logo

Sangart

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical oxygen-therapeutic agents, pursuing global scientific, clinical and commercial development.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sangart

LeMaitre Logo

LeMaitre

HQ: United States Website
  • Description: Provider of medical devices and implants for the treatment of peripheral vascular diseases, including RestoreFlow, a tissue processing division supplying human tissue allografts for peripheral vascular and cardiac disease, and the LeMaitre Valvulotome, a device that cuts valves in peripheral veins without direct vision for lower extremity arterial disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LeMaitre company profile →
EPD Solutions Logo

EPD Solutions

HQ: Spain Website
  • Description: Provider of cardiac imaging and navigation systems, dedicated to improving the efficacy and efficiency of minimally invasive catheter-based procedures to treat cardiac arrhythmias; a Dutch company and member of the Hobart Group companies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EPD Solutions company profile →
Silvergate Pharmaceuticals Logo

Silvergate Pharmaceuticals

HQ: United States Website
  • Description: Provider of pediatric medications, developing and commercializing innovative oral solutions that improve dosing accuracy, safety, and availability. Products include Xatmep (methotrexate) for pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis; Qbrelis (lisinopril) for hypertension (adults/pediatric 6+), adjunct heart failure, and acute MI in adults; and EPANED (enalapril) for hypertension (adults/pediatric >1 month), symptomatic heart failure, and asymptomatic left ventricular dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Silvergate Pharmaceuticals company profile →
Cordis Logo

Cordis

HQ: United States Website
  • Description: Provider of less invasive treatments for vascular disease as a Johnson & Johnson company, and developer/manufacturer of stents, catheters, and guidewires. Offerings include SELUTION SLR Drug-Eluting Balloon for controlled, sustained sirolimus release; BRITE TIP Guiding Catheter; MYNX CONTROL Vascular Closure Device; RAIN Sheath Transradial thin-walled introducer; and RAILWAY Sheathless Access System.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cordis company profile →
Affera Logo

Affera

HQ: United States Website
  • Description: Provider of an integrated platform for cardiac arrhythmia treatment delivering durable therapy for a wide range of patients, and pulsed field ablation for atrial fibrillation using a lattice-tip focal catheter.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Affera company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sangart

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sangart

2.2 - Growth funds investing in similar companies to Sangart

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sangart

4.2 - Public trading comparable groups for Sangart

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sangart

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sangart

What does Sangart do?

Sangart is a provider of biopharmaceutical oxygen-therapeutic agents, pursuing global scientific, clinical and commercial development.

Who are Sangart's competitors?

Sangart's competitors and similar companies include LeMaitre, EPD Solutions, Silvergate Pharmaceuticals, Cordis, and Affera.

Where is Sangart headquartered?

Sangart is headquartered in United States.

How many employees does Sangart have?

Sangart has 1,000 employees 🔒.

When was Sangart founded?

Sangart was founded in 2010 🔒.

What sector and industry vertical is Sangart in?

Sangart is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sangart

Who are the top strategic acquirers in Sangart's sector and industry

Top strategic M&A buyers and acquirers in Sangart's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sangart?

Top strategic M&A buyers groups and sectors for Sangart include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sangart's sector and industry vertical

Which are the top PE firms investing in Sangart's sector and industry vertical?

Top PE firms investing in Sangart's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sangart's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sangart's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sangart's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sangart include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sangart's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sangart?

The key public trading comparables and valuation benchmarks for Sangart include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sangart for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sangart with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sangart's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sangart with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sangart's' sector and industry vertical?

Access recent funding rounds and capital raises in Sangart's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sangart